Hims & Hers Health Inc (NYSE: HIMS) kicked off on Monday, down -4.25% from the previous trading day, before settling in for the closing price of $32.22. Over the past 52 weeks, HIMS has traded in a range of $8.09-$35.02.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Consumer Defensive sector has jumped its sales by 60.52% annually for the last half of the decade. While this was happening, its average annual earnings per share was recorded 824.74%. With a float of $177.25 million, this company’s outstanding shares have now reached $209.44 million.
In an organization with 1046 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 77.58%, operating margin of 2.84%, and the pretax margin is 4.16%.
Hims & Hers Health Inc (HIMS) Insider Updates
Our next focus will be how large-scale investors are participating in this stock of the Household & Personal Products Industry. The insider ownership of Hims & Hers Health Inc is 18.87%, while institutional ownership is 56.02%. The most recent insider transaction that took place on Dec 02 ’24, was worth 68,932. Before that another transaction happened on Dec 02 ’24, when Company’s Officer proposed sale 33,513 for $33.38, making the entire transaction worth $1,118,655.
Hims & Hers Health Inc (HIMS) Performance Highlights and Predictions
According to the Wall Street analysts, stocks earnings will be around 824.74% per share during the next fiscal year.
Hims & Hers Health Inc (NYSE: HIMS) Trading Performance Indicators
Take a look at Hims & Hers Health Inc’s (HIMS) current performance indicators. Last quarter, stock had a quick ratio of 1.82. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 5.76. Likewise, its price to free cash flow for the trailing twelve months is 47.84.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 0.43, a number that is poised to hit 0.18 in the next quarter and is forecasted to reach 0.89 in one year’s time.
Technical Analysis of Hims & Hers Health Inc (HIMS)
Let’s dig in a bit further. During the last 5-days, its volume was 23.94 million. That was better than the volume of 9.83 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 74.97%. Additionally, its Average True Range was 2.99.
During the past 100 days, Hims & Hers Health Inc’s (HIMS) raw stochastic average was set at 80.65%, which indicates a significant increase from 73.72% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 178.43% in the past 14 days, which was higher than the 102.57% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $22.02, while its 200-day Moving Average is $17.95. However, in the short run, Hims & Hers Health Inc’s stock first resistance to watch stands at $32.99. Second resistance stands at $35.13. The third major resistance level sits at $36.26. If the price goes on to break the first support level at $29.71, it is likely to go to the next support level at $28.58. Assuming the price breaks the second support level, the third support level stands at $26.44.
Hims & Hers Health Inc (NYSE: HIMS) Key Stats
The company with the Market Capitalisation of 7.16 billion has total of 218,479K Shares Outstanding. Its annual sales at the moment are 872,000 K in contrast with the sum of -23,550 K annual income. Company’s last quarter sales were recorded 401,560 K and last quarter income was 75,590 K.
